The organic cation transporter OCT2 exists in dopamine-rich brain areas

被引：0
|
作者：
Kiefer, N [1 ]
Martel, F [1 ]
Grundemann, D [1 ]
Schömig, E [1 ]
机构：
[1] Univ Heidelberg, Dept Pharmacol, D-69120 Heidelberg, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 1998年 / 357卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
83
引用
收藏
页码：R24 / R24
页数：1
相关论文
共 50 条
  • [31] Genetic variants of organic cation transporter 2 (OCT2) significantly reduce metformin uptake in oocytes
    Song, I. S.
    Shin, H. J.
    Shin, J. G.
    XENOBIOTICA, 2008, 38 (09) : 1252 - 1262
  • [32] Irinotecan Alters the Disposition of Morphine Via Inhibition of Organic Cation Transporter 1 (OCT1) and 2 (OCT2)
    Peng Zhu
    Zhi Ye
    Dong Guo
    Zongping Xiong
    Shiqiong Huang
    Jun Guo
    Wei Zhang
    James E. Polli
    Honghao Zhou
    Qing Li
    Yan Shu
    Pharmaceutical Research, 2018, 35
  • [33] Genetic variants of organic cation transporter 1 (OCT1) and OCT2 significantly reduce lamivudine uptake
    Choi, Min-Koo
    Song, Im-Sook
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2012, 33 (03) : 170 - 178
  • [34] Structural determinants of inhibitor interaction with the human organic cation transporter OCT2 (SLC22A2)
    Zolk, Oliver
    Solbach, Thomas F.
    Koenig, Joerg
    Fromm, Maring F.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 379 (04) : 337 - 348
  • [35] Structural determinants of inhibitor interaction with the human organic cation transporter OCT2 (SLC22A2)
    Oliver Zolk
    Thomas F. Solbach
    Jörg König
    Martin F. Fromm
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2009, 379 : 337 - 348
  • [36] Combinatorial Pharmacophore Modeling of Organic Cation Transporter 2 (OCT2) Inhibitors: Insights into Multiple Inhibitory Mechanisms
    Xu, Yuan
    Liu, Xian
    Li, Shanshan
    Zhou, Nannan
    Gong, Likun
    Luo, Cheng
    Luo, Xiaomin
    Zheng, Mingyue
    Jiang, Hualiang
    Chen, Kaixian
    MOLECULAR PHARMACEUTICS, 2013, 10 (12) : 4611 - 4619
  • [37] Effects of genetic variants of organic cation transporter 2 (OCT2) on the pharmacokinetics of metformin in healthy subjects.
    Song, I.
    Shin, H.
    Shim, E.
    Jung, I.
    Kim, W.
    Shon, J.
    Shin, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S84 - S84
  • [38] Transport of the dopamine D2 agonist pramipexole by rat organic cation transporters OCT1 and OCT2 in kidney
    Ishiguro, N
    Saito, A
    Yokoyama, K
    Morikawa, M
    Igarashi, T
    Tamai, I
    DRUG METABOLISM AND DISPOSITION, 2005, 33 (04) : 495 - 499
  • [39] Assessment of Substrate Dependent Ligand Interactions at the Organic Cation Transporter OCT2 Using Six Model Substrates
    Sandoval, Philip Joseph
    Wright, Stephen H.
    FASEB JOURNAL, 2017, 31
  • [40] Substrate-Dependent Inhibition of the Human Organic Cation Transporter OCT2: A Comparison of Metformin with Experimental Substrates
    Hacker, Kristina
    Maas, Renke
    Kornhuber, Johannes
    Fromm, Martin F.
    Zolk, Oliver
    PLOS ONE, 2015, 10 (09):
12345